Clinical Trials Interview June 2022, page-9

Yes a commercial valuation is required immediately of the Company and its IP Suite.
You will note that RAP BOD have had to at the request of SH gain a Commercial Valuation of the Company before further negotiations with Pfizer.
Standard Business Operating Procedure..

So PAA have booked a Facility for the Humanised Mouse Trial according to Roger ,, and the last announcement , so why keep it secret? where? When? who? duration?

Roger back in Oxford , might want to get a PAA backdrop or at least wind that clock up....


I have some near opportunities to move to , regrettably with no clear timeline here we can only expect further decline until a clear timeline is put forward,,, every trial at this company has been delayed in excess of a year. Not sure cancelling a Trial is a saving to SH?? more like a little more cash to stave off an immediate CR and if we have saved $1.5 then why the need for the Factoring in from a Finance company for the R &D rebates.
More twists than the Da Vinci Code....

Many where holding on for the Human Covid Trial as it would have been short ... now its been reduced to a mouse sometime in the future?
This after 6 announcements identifying Ergomed? Poland????????? are you &%&*^*ng joking..

Company has isolated itself from the rest of the Biotech sector by not participating in the same manner,,,

Best of luck to all holders,,,NZT